Vanguard Group Inc Repligen Corp Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Repligen Corp stock. As of the latest transaction made, Vanguard Group Inc holds 5,100,013 shares of RGEN stock, worth $760 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,100,013
Previous 5,078,294
0.43%
Holding current value
$760 Million
Previous $913 Million
2.73%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$1.16 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$532 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$262 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$218 Million0.31% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.43MShares$214 Million0.77% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.27B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....